Sinopharm
1099.HK
#1835
Rank
NZ$15.60 B
Marketcap
$5.00
Share price
1.15%
Change (1 day)
26.37%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total assets

Total assets on the balance sheet as of December 2023 : NZ$95.94 Billion

According to Sinopharm's latest financial reports the company's total assets are NZ$95.94 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sinopharm - Total assets on balance sheet (from 2008 to 2023)

Total assets by year

Year Total assets Change
2022-12-31NZ$83.26 B8.05%
2021-12-31NZ$77.06 B16.52%
2020-12-31NZ$66.13 B15.29%
2019-12-31NZ$57.36 B12.24%
2018-12-31NZ$51.10 B23.84%
2017-12-31NZ$41.27 B25.87%
2016-12-31NZ$32.78 B4.32%
2015-12-31NZ$31.43 B18.53%
2014-12-31NZ$26.51 B25.06%
2013-12-31NZ$21.20 B34.06%
2012-12-31NZ$15.81 B14.73%
2011-12-31NZ$13.78 B67.4%
2010-12-31NZ$8.23 B25.16%
2009-12-31NZ$6.58 B61.35%
2008-12-31NZ$4.07 B59.49%
2007-12-31NZ$2.55 B21.33%
2006-12-31NZ$2.10 B